Zvi Fishelson

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

Journal: Nature communications

Published: February 17, 2026

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

Journal: Nature communications

Published: February 17, 2026

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

Journal: bioRxiv : the preprint server for biology

Published: August 06, 2025

Potent neutralization by antibodies targeting the MPXV A28 protein.

Potent neutralization by antibodies targeting the MPXV A28 protein.

Journal: Nature communications

Published: June 25, 2025

Comprehensive Analysis of Thrombotic Microangiopathy Following Renal Transplantation.

Comprehensive Analysis of Thrombotic Microangiopathy Following Renal Transplantation.

Journal: International journal of nephrology

Published: March 26, 2024

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.

Journal: Frontiers in immunology

Published: November 12, 2023

Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress.

Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress.

Journal: Biomedicines

Published: May 30, 2023

Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity.

Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity.

Journal: International journal of oncology

Published: February 20, 2020

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.

Journal: Frontiers in immunology

Published: January 31, 2019

MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity.

MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity.

Journal: Cancer immunology research

Published: November 15, 2018

Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.

Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.

Journal: Frontiers in immunology

Published: December 20, 2017

Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9.

Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9.

Journal: Cell death & disease

Published: May 18, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026